BioCentury
ARTICLE | Regulation

Realities of real-world evidence

How regulators, drug companies and payers can expand RWE from safety to efficacy

October 20, 2017 6:49 PM UTC

After countless conferences, white papers and speeches, stakeholders across the healthcare ecosystem are finally coming together to figure out how to extend the use of real-world evidence beyond pharmacovigilance and into drug development.

The payoffs from creating efficient systems for generating real-world evidence (RWE) as a complement to evidence generated in randomized, controlled trials (RCTs) have long been clear...